Our Opinion

Medigus Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“The company will present findings from an animal feasibility study, Reflux Disease Treatment – MUSE™ (formerly SRS™) Procedure Combined with POEM in the Treatment of Achalasia: A Feasibility Study in an Animal Model, during Poster Session # 1623 at the upcoming United European Gastroenterology Week (UEGW), being held in Vienna, Austria, from October 18 – 22, 2014.” Read the following article

Company Description

Medigus Ltd. is a medical device company, which engages in the research and development, manufacture, and sale of endosurgical tools and instruments. It specializes in the area of Gastroesophageal reflux disease. Its product MUSE System offers minimal invasive endoscopic devices and procedures for gastric surgery. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Omer, Israel. [Source: MarketWatch]

Company Website: http://www.medigus.com